Clinical trials: Natural Daylight Photodynamic Therapy
Actinic Keratosis, Natural Daylight Photodynamic Therapy
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
This study compares two photosensitizing creams' BF-200 ALA's (aminolevulinic acid, Ameluz®) and MAL's (methyl 5-aminolevulinate, Metvix®) efficacy on actinic keratoses in natural daylight photodynamic therapy (NDL-PDT).
- Trial name
- NCT02464709
- Testing
- Aminolevulinic Acid, Methyl 5-aminolevulinate
- Where
- 3 sites in Finland
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Joint Authority for Päijät-Häme Social and Health Care